Targeting CD38 with monoclonal antibodies disrupts key survival pathways in paediatric Burkitt's lymphoma malignant B cells.
Kläsener K, Herrmann N, Håversen L, Sundell T, Sundqvist M, Lundqvist C, Manna PT, Jonsson CA, Visentini M, Ljung Sass D, McGrath S, Grimstad K, Aranburu A, Mellgren K, Fogelstrand L, Forsman H, Ekwall O, Borén J, Gjertsson I, Reth M, Mårtensson IL, Camponeschi A.
Kläsener K, et al. Among authors: boren j.
Clin Transl Immunology. 2024 Oct 3;13(10):e70011. doi: 10.1002/cti2.70011. eCollection 2024.
Clin Transl Immunology. 2024.
PMID: 39364393
Free PMC article.